Guselkumab is the first and only interleukin-23 inhibitor that offers both subcutaneous and intravenous induction options for ...

The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...

Johnson & Johnson's Tremfya gains FDA approval for Crohn's disease, backed by Phase 3 trial data and demonstrating ...

The FDA expanded the approval of guselkumab (Tremfya) to include treatment of moderately to severely active Crohn's disease, drugmaker Johnson & Johnson announced on Thursday. An interleukin (IL)-23 ...

BUT IN SOME CASES, IT COULD BE CROHN’S. YEAH. I MEAN, IRRITABLE BOWEL SYNDROME IS VERY COMMON. UP TO 15% OF OF THE COUNTRY HAS IRRITABLE BOWEL SYNDROME. BUT THERE ARE SOME OTHER CONDITIONS THAT ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Apr. 24, 2024 — Study ...

Fatigue can greatly affect your quality of life. Fatigue might be a sign that you need to adjust your treatment regimen for Crohn’s disease. Talk with your doctor about options for managing ...

If you have Crohn’s disease, symptoms such as abdominal pain and frequent bowel movements can prevent you from getting enough quality sleep and rest. These are just some of the reasons why ...

Changes in bowel movements, such as blood in your poop, can be a sign that an individual’s Crohn’s disease is flaring up. So, even if you’ve already been diagnosed with Crohn’s disease ...

Crohn’s disease is a type of inflammatory bowel disease (IBD) that can cause stomach cramps. Most people with Crohn’s experience frequent and severe cramps during a flare-up, but they can ...

It’s possible that your Crohn’s symptoms may be severe enough to impact your quality of life. They may also increase the risk for additional health problems. People with Crohn’s are ...